NOV 18, 2020 9:43 AM PST

Could Targeting the Proteasome be Effective Against Cancer?

WRITTEN BY: Jasper Cantrell

One of the trickiest things about anti-cancer drug design is targeting. Today, most drugs on the market target critical cell cycle or cell surface proteins, with new research identifying new targets every day.

In a new study out of the University of Toyama in Japan, a team conducted a screen and identified a possible protein target for cancer therapeutics. This target, called PMSD14, was tied to something called the proteasome, which has been on researchers’ radar for potential cancer therapeutics for a while now.

The proteasome is the primary protein disposal tool in most cells. An old or defective protein is tagged with something called ubiquitin, which targets that protein to the proteasome. The proteasome then shreds it into small pieces. The protein that the team identified is called PSMD14, which is responsible for un-tagging ubiquitinated proteins. It has also been linked to cancer in other studies.

The study first identified PSMD14 as a promoter of melanoma growth. The team then attempted to figure out the mechanism in which it worked. They analyzed genes that correlated one way or another with PSMD14’s loss. The team then examined how PSMD14 loss in melanoma cells affected growth and metastatic characteristics.

They began by knocking out the PSMD14 gene in a melanoma cell line. A previous study pointed to this knockout affecting cell cycle inhibitor proteins p21 and RB. The cell cycle is how cells grow and divide, so its inhibition effectively kills a cell. Indeed, PSMD14 knockout upregulated p21 expression and activated RB. Therefore, inhibiting PSMD14 with a drug could activate these two cell cycle inhibitors and impair melanoma growth.

The proteasome presents an interesting but complex target for anti-cancer therapeutics. This study shines a light on not the proteasome but on one of its assisting proteins. PSMD14 knockout in melanoma results in the activation and upregulation of CDK inhibitors RB and p21, which impairs the growth of melanoma cells in vitro. Targeting PSMD14 would allow scientists to selectively target the proteasome without inducing catastrophic dysfunction, although far more research needs to be done to ensure it would work.

The study concludes, “Although we identified PSMD14 as a molecular target for melanoma, there is currently no available drug targeting PSMD14. As the disturbance of proteasome function by PSMD14 knockdown may affect melanoma growth, proteasome inhibitors, including bortezomib, may be attractive drugs for melanoma.”

Sources: Nature Scientific Reports, Myeloma UK

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
OCT 06, 2020
Cannabis Sciences
Cannabis Use May Reduce Cancer Risk by 10%
OCT 06, 2020
Cannabis Use May Reduce Cancer Risk by 10%
A recent meta-analysis of 34 studies found that cannabis use may decrease one’s risk of developing certain kinds o ...
OCT 04, 2020
Cancer
Mutations form in specific genomic patterns based on external and internal factors
OCT 04, 2020
Mutations form in specific genomic patterns based on external and internal factors
New research published in Nature Genetics provides insight on the formation of mutations in the genome. Researchers from ...
NOV 09, 2020
Genetics & Genomics
Potential Problems with Liquid Biopsies
NOV 09, 2020
Potential Problems with Liquid Biopsies
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...
NOV 12, 2020
Immunology
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
NOV 12, 2020
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
Nutrition is essential to health; what we eat in our daily diet affects our overall health condition and what diseases w ...
NOV 26, 2020
Immunology
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
NOV 26, 2020
Armed With ImmunoBait, Red Blood Cells Fight Lung Cancers
  There’s a new weapon in the battle against lung cancer metastases: red blood cells equipped with nanopartic ...
NOV 30, 2020
Cancer
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
NOV 30, 2020
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
Many take modern surgeons and surgical methods for granted. In the grand scheme of things, it wasn’t too long ago ...
Loading Comments...